TCMD is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of TCMD shares has held flat since the market last closed. This is a 0.00% change ...

MINNEAPOLIS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with ...

GAAP revenue surpassed expectations in Q2 2025, driven by 52% growth in the airway clearance (AffloVest) segment. GAAP gross margin improved to 75% in Q2 2025, but net income (GAAP) and Adjusted ...

(MENAFN- GlobeNewsWire - Nasdaq) Abstract Presented at ASCO 2025 Annual Meeting Features Two-Month Data from the Largest Randomized Trial Ever Conducted Among Head and Neck Cancer Survivors ...

MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with ...

Abstract Presented at ASCO 2025 Annual Meeting Features Two-Month Data from the Largest Randomized Trial Ever Conducted Among Head and Neck Cancer Survivors MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) ...

Tactile Systems Technology Inc (NASDAQ:TCMD), a leader in at-home treatments for chronic conditions, presented its latest investor slides on May 5, 2025, highlighting both opportunities and challenges ...

Tactile Systems produces medical devices for lymphedema and chronic venous insufficiency, with Flexitouch Plus being the flagship product and key revenue driver. The company's products are covered by ...